RYBREVANT
Concentrate for solution for infusion, 350mg
RxActive license
Active substance (INN)
amivantamab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength350mg
PackagingUkupno jedna bočica staklena sa 7ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerJanssen Biologics B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L01FX18)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateNovember 25, 2025
Source: CInMED register